Source: Annual Congress 2004 - Clinical aspects of OSA
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. J. Williams, J. E. Black (London, United Kingdom; Stanford, United States Of America). Efficacy and safety of modafinil as an adjunctive therapy for excessive sleepiness associated with obstructive sleep apnoea. Eur Respir J 2004; 24: Suppl. 48, 799

Member's Comments

No comment yet.

Related content which might interest you: Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019 Efficacy testing for oral appliance therapy in obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Efficacy of a FOT-based auto-CPAP device for the treatment of obstructive sleep apnea Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 Efficacy and safety of single-use suvorexant for insomnia during in-laboratory polysomnography in patients with obstructive sleep apnea: A feasibility study Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Efficacy of adaptive servo-ventilation on residual sleepiness in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Outcome of adaptive servo ventilation in sleep apnoea Year: 2008 Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Oral devices in the treatment of obstructive sleep apnoea short and long-term treatment Source: Eur Respir J 2003; 22: Suppl. 45, 95s Year: 2003 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Determinants of subjective sleepiness in suspected obstructive sleep apnoea Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008 Objective compliance with oral appliance therapy versus CPAP in moderate obstructive sleep apnea Source: International Congress 2017 – CPAP therapy Year: 2017 Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002 Clinical implications of residual sleep apnoea after chronic CPAP therapy Source: Breathe 2011; 7: 289-290 Year: 2011 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Long-term CPAP compliance in women with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Daytime sleepiness in patients with treated obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 594s Year: 2007 Diagnosing excessive daytime sleepiness in obstructive sleep apnoea Source: 5th Sleep and Breathing Conference Year: 2019